KYUNG NAM PHARM CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,420 KRW | +15.35% |
|
+15.92% | -15.58% |
| 2023 | Kyung Nam Pharm Co.,Ltd. announced that it has received KRW 5 billion in funding | CI |
| 2023 | Kyung Nam Pharm Co.,Ltd. announced that it expects to receive KRW 5 billion in funding | CI |
Business Summary
Number of employees: 230
Sales per Business
| KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 59,000 | 100.0 % | 68,445 | 100.0 % | +16.01% |
Sales per region
| KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
South Korea
100.0
%
| 54,237 | 93.4 % | 68,445 | 100.0 % | +26.20% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Seong-Won Oh
CEO | Chief Executive Officer | 46 | - |
Seung-Jae Lim
AUD | Comptroller/Controller/Auditor | 77 | - |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Byung-Jin Kim
BRD | Director/Board Member | 46 | - |
Seong-Won Oh
CEO | Chief Executive Officer | 46 | - |
Hyeon-Bo Yoon
BRD | Director/Board Member | 53 | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 35,593,402 | 25,655,158 ( 72.08 %) | 287 ( 0.000806 %) | 72.08 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
KYUNG NAM PHARM CO.,LTD. 0.00% | 287 | 0.00% | 256 $ |
| 0 | -.--% | 0 $ |
Company contact information
Kyungnam Pharm Co., Ltd.
79 Guryong-ro 4nam-gil Uiryeong-eup
52153, Uiryeong-gun
+
http://www.kyungnampharm.co.kr
Sector
Sales per region
| 1st Jan change | Capi. | |
|---|---|---|
| -15.58% | 37.35M | |
| +21.63% | 44.11B | |
| +23.79% | 22.71B | |
| +18.22% | 15.15B | |
| +12.66% | 13.56B | |
| +60.18% | 12.7B | |
| -8.60% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.63B |
- Stock Market
- Equities
- A053950 Stock
- Company Kyung Nam Pharm Co.,Ltd.
